Search Results 1951-1960 of 14270 for testosterone
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
SCAI expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory ( ...
Seabrook R, Bendel-Stenzel E, Riddle S. EX-Utero Intrapartum Therapy: Introduction to EXIT Procedures Website Publications of the Children's Hospitals Neonatal ...
September is Prostate Cancer Awareness Month. It's one of the leading causes of cancer death among all men. However, Black men are disproportionately hit ...
Sawal N, Pennington KM, Petrossian R, Reisenauer J, Mullon J, Midthun D, Nelson D, Anderson D, Edell E, Saddoughi SA, Spencer PJ, Villavicencio MA, Kennedy CC, ...
Daniels P, Vlazny D, Meverden R, Bartlett M, Hesley G, Lekah A, Macedo T, Wysokinski WE, Houghton DE. Popliteal cysts are not a risk factor for lower ...
The hypothesis is that using genotypic variation in CYP2D6 to select the appropriate 5HT3 serotonin receptor antagonist to treat PONV will decrease rates of ...
From diet and stress ... to age and genetics ... they all play a role in success or failure when trying to conceive. On this week's program, Dr. Jani Jensen, a ...
The purpose of this study is to determine if prostate cancer patients treated with proton therapy as compared to IMRT experience improved QOL (validated EPIC ...
Ravi SN, Cheema KP, Taylor GE. 52-Year-Old Woman With Recurrent Unexplained Syncope. Mayo Clin Proc. 2024 Jul; 99 (7):1173-1177 Epub 2024 June 01
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.